Page 45 - Read Online

Page 14 of 14 Calderwood et al. Plast Aesthet Res 2021;8:40 https://dx.doi.org/10.20517/2347-9264.2021.14

34. Clough RE. Magnetic resonance imaging to guide surgical practice. Eur J Vasc Endovasc Surg 2012;43:112-3. DOI PubMed
35. Torres Lacomba M, Yuste Sánchez MJ, Zapico Goñi A, et al. Effectiveness of early physiotherapy to prevent lymphoedema after
surgery for breast cancer: randomised, single blinded, clinical trial. BMJ 2010;340:b5396. DOI PubMed PMC
36. Mihara M, Hara H, Araki J, et al. Indocyanine green (ICG) lymphography is superior to lymphoscintigraphy for diagnostic imaging of
early lymphedema of the upper limbs. PLoS One 2012;7:e38182. DOI PubMed PMC
37. Becker C, Assouad J, Riquet M, Hidden G. Postmastectomy lymphedema: long-term results following microsurgical lymph node
transplantation. Ann Surg 2006;243:313-5. DOI PubMed PMC
38. Lin CH, Ali R, Chen SC, et al. Vascularized groin lymph node transfer using the wrist as a recipient site for management of
postmastectomy upper extremity lymphedema. Plast Reconstr Surg 2009;123:1265-75. DOI PubMed
39. Brorson H. Liposuction gives complete reduction of chronic large arm lymphedema after breast cancer. Acta Oncol 2000;39:407-20.
DOI PubMed
40. Brorson H, Svensson H. Liposuction combined with controlled compression therapy reduces arm lymphedema more effectively than
controlled compression therapy alone. Plast Reconstr Surg 1998;102:1058-67; discussion 1068. PubMed
41. Ridner SH, Dietrich MS, Cowher MS, et al. A randomized trial evaluating bioimpedance spectroscopy versus tape measurement for
the prevention of lymphedema following treatment for breast cancer: interim analysis. Ann Surg Oncol 2019;26:3250-9. DOI PubMed
PMC
42. Semelka RC, Ramalho M, Jay M. Summary of special issue on gadolinium bioeffects and toxicity with a look to the future. Magn
Reson Imaging 2016;34:1399-401. DOI PubMed
43. Guideline on the use of gadolinium-containing MRI contrast agents in patient with renal impairment, Version 3. 2019, The Royal
Australian and New Zealand College of Radiologists. Available from: https://www.ranzcr.com/documents/553-revised-college-
guidelines-for-gadolinium-containing-mri-contrast-agents/file. [Last accessed on 5 Aug 2021].
44. Gulani V, Calamante F, Shellock FG, Kanal E, Reeder SB. Gadolinium deposition in the brain: summary of evidence and
recommendations. Lancet Neurol 2017;16:564-70. DOI PubMed
45. Murata N, Murata K, Gonzalez-Cuyar LF, Maravilla KR. Gadolinium tissue deposition in brain and bone. Magn Reson Imaging
2016;34:1359-65. DOI PubMed
46. FDA Drug Safety Communication: FDA warns that gadolinium-based contrast agents (GBCAs) are retained in the body; requires new
class warnings. Available from: https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-warns-
gadolinium-based-contrast-agents-gbcas-are-retained-body. [Last accessed on 5 Aug 2021].
47. Miseré RML, Wolfs JAGN, Lobbes MBI, van der Hulst RRWJ, Qiu SS. A systematic review of magnetic resonance lymphography for
the evaluation of peripheral lymphedema. J Vasc Surg Venous Lymphat Disord 2020;8:882-92.e2. DOI PubMed